// App-Quantinova.ai

4077 : Quantitative proteomics reveals novel immunomodulatory pathways of resistance to PARP therapy

Researchers

Presenter

  • Jakob Vowinckel

Principal Investigators

  • Yuehan Feng

  • Dimitra Georgopoulou

  • Alejandra Bruna

  • Tobias Treiber

  • Abigail Shea

  • Giulia Lerda

  • Martin O'Reilly

  • Kristina Beeler

  • Carlos Caldas

Medical Centers

  • Biognosys, Schlieren, Switzerland,

  • Cancer Research UK, Cambridge Research Institute, Cambridge, United Kingdom

Locations

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • Talazoparib

  • Olaparib

  • BMN-673

  • BMN 673

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved